CN101503373A - 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途 - Google Patents

2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途 Download PDF

Info

Publication number
CN101503373A
CN101503373A CN 200910019817 CN200910019817A CN101503373A CN 101503373 A CN101503373 A CN 101503373A CN 200910019817 CN200910019817 CN 200910019817 CN 200910019817 A CN200910019817 A CN 200910019817A CN 101503373 A CN101503373 A CN 101503373A
Authority
CN
Grant status
Application
Patent type
Prior art keywords
inhibitor
relates
invention
amino
ethanol
Prior art date
Application number
CN 200910019817
Other languages
English (en)
Chinese (zh)
Other versions
CN101503373B (zh )
Inventor
徐文方
浩 方
杨康辉
Original Assignee
山东大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of products other than chlorine, adipic acid, caprolactam, or chlorodifluoromethane, e.g. bulk or fine chemicals or pharmaceuticals
    • Y02P20/55Synthetic design, e.g. reducing the use of auxiliary or protecting groups
CN 200910019817 2009-03-13 2009-03-13 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途 CN101503373B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910019817 CN101503373B (zh) 2009-03-13 2009-03-13 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910019817 CN101503373B (zh) 2009-03-13 2009-03-13 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途

Publications (2)

Publication Number Publication Date
CN101503373A true true CN101503373A (zh) 2009-08-12
CN101503373B CN101503373B (zh) 2013-07-24

Family

ID=40975766

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910019817 CN101503373B (zh) 2009-03-13 2009-03-13 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途

Country Status (1)

Country Link
CN (1) CN101503373B (it)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009109850A3 (en) * 2008-03-06 2009-12-10 Novaremed Ltd. N-substitutedbenzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
US8252843B2 (en) 2004-03-26 2012-08-28 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
US8309606B2 (en) 2002-10-03 2012-11-13 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
WO2013026942A1 (en) 2011-08-25 2013-02-28 The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Tubulin binding agents
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1566065A (zh) 2003-06-27 2005-01-19 中国医学科学院药物研究所 α位杂原子取代的γ芳基丁本酮酸衍生物及其制法和其药物组合物与用途

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309606B2 (en) 2002-10-03 2012-11-13 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
US8252843B2 (en) 2004-03-26 2012-08-28 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
WO2009109850A3 (en) * 2008-03-06 2009-12-10 Novaremed Ltd. N-substitutedbenzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
US8883853B2 (en) 2008-03-06 2014-11-11 Novaremed Limited N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
WO2013026942A1 (en) 2011-08-25 2013-02-28 The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Tubulin binding agents

Also Published As

Publication number Publication date Type
CN101503373B (zh) 2013-07-24 grant

Similar Documents

Publication Publication Date Title
US5055451A (en) Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
US5208236A (en) N-(acylaminomethyl)glutaryl amino acids and use
US5158936A (en) Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
US6436925B1 (en) Substituted benzamides, their production and their use as cysteine protease inhibitors
WO2002085899A1 (en) Heterocyclyldicarbamides as caspase inhibitors
EP0721944B1 (en) Imidazolidine derivative and use thereof
EP1074542A1 (en) Sulfonamide-containing indole compounds
WO2013039187A1 (ja) グアニジノ安息香酸化合物
US5665753A (en) Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
US20040234622A1 (en) Sulfonamide derivatives
US20070219239A1 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
US20080261998A1 (en) Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
EP1445250A1 (en) Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same
WO2000066104A2 (en) Ace-2 inhibiting compounds and methods of use thereof
Fujisawa et al. Highly water-soluble matrix metalloproteinases inhibitors and their effects in a rat adjuvant-induced arthritis model
JP2004250401A (ja) オキサゾール誘導体
US6462063B1 (en) C-proteinase inhibitors
WO2010059953A1 (en) Quinazoline inhibitors of bace 1 and methods of using
US20100113391A1 (en) Bicyclic heterocyclic compound
WO2010053120A1 (ja) カルバメート化合物又はその塩
JP2004514669A (ja) セリンプロテアーゼ阻害剤として有用な酸誘導体
JP2002509908A (ja) アミノシクロヘキシルエーテル化合物およびその用途
Gu et al. Toward the development of chemoprevention agents. Part II: Chemo-enzymatic synthesis and anti-inflammatory activities of a new class of 5-amino-2-substitutedphenyl-1, 3-dioxacycloalkanes
JPH10204054A (ja) フェニルスルホンアミド誘導体
JP2004250400A (ja) ピリミジン誘導体

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
C14 Grant of patent or utility model
CF01